OST Group becomes a shareholder in July 2019
posted July 08, 2019
Several companies are evaluating Messenger Biopharma’s Aegis biotechnology
posted September 03, 2018
From this Summer on, a few companies, dedicated to research ...Read More
Messenger Biopharma is perfecting a biotechnology of in vivo mRNA transfection, which has been patented. This biotechnology tends to optimize the process of mRNA delivery to mammalian cells, as well as the mRNA sequence.